Cost-effectiveness analysis of human papillomavirus vaccines for the prevention of cervical cancer in India.

Arora, Shiksha; Tuffaha, Haitham

Arora, Shiksha; Tuffaha, Haitham.

Affiliation

Arora S; The Centre for the Business and Economics of Health, The University of Queensland, Brisbane, Queensland, Australia.
Tuffaha H; The Centre for the Business and Economics of Health, The University of Queensland, Brisbane, Queensland, Australia.

Asia Pac J Clin Oncol ; 20(1): 55-62, 2024 Feb.

Article in En | MEDLINE | ID: mdl-37132538

Subject(s)

Papillomavirus Infections; Papillomavirus Vaccines; Uterine Cervical Neoplasms; Female; Humans; Child; Papillomavirus Vaccines/therapeutic use; Cost-Effectiveness Analysis; Papillomavirus Infections/epidemiology; Papillomavirus Infections/prevention & control; Uterine Cervical Neoplasms/epidemiology; Uterine Cervical Neoplasms/prevention & control; Cost-Benefit Analysis; Vaccines, Combined; Quality-Adjusted Life Years

Key words

HPV vaccination; India; cervical cancer; costeffectiveness; economic evaluation

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Uterine Cervical Neoplasms / Papillomavirus Infections / Papillomavirus Vaccines Type of study: Health_economic_evaluation / Prognostic_studies Aspects: Patient_preference Limits: Child / Female / Humans Language: En Journal: Asia Pac J Clin Oncol Journal subject: NEOPLASIAS Year: 2024 Document type: Article Affiliation country: Australia Country of publication: Australia

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google